Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

sections
  • 1 of 2

mTOR inhibition in several solid malignancies, such as renal cell carcinoma, neuroendocrine carcinoma, breast cancer, glioblastoma multiforme and endometrial cancer, has shown promising progression-free and overall survival in clinical studies